Avacta Group Plc (LON:AVCT)‘s stock had its “corporate” rating restated by investment analysts at FinnCap in a research note issued to investors on Monday.

Separately, Numis Securities Ltd reissued a “buy” rating on shares of Avacta Group Plc in a research report on Monday, August 1st.

Avacta Group Plc (LON:AVCT) opened at 89.00 on Monday. The stock has a 50 day moving average price of GBX 96.65 and a 200-day moving average price of GBX 100.28. Avacta Group Plc has a 1-year low of GBX 83.02 and a 1-year high of GBX 141.50. The company’s market cap is GBX 59.75 million.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/17/avacta-group-plc-avct-receives-corporate-rating-from-finncap.html

Avacta Group Plc Company Profile

Avacta Group plc is a provider of research reagents, consumables and equipment to the life sciences and animal care markets. The Company provides research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology.

Receive News & Ratings for Avacta Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.